APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.
Journal Information
Full Title: Curr Atheroscler Rep
Abbreviation: Curr Atheroscler Rep
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of InterestAntonina Giammanco declares no competing interests. Rossella Spina declares no competing interests. Angelo Baldassare Cefalù has received personal fees for consultancy or grant support from Amryt, Sanofi, and Sobi. Maurizio Averna has received research grant support from Sanofi and Amryt and has served as consultant for Sanofi, Amgen, Amryt, Akcea, Ionis, Alfasigma, and Pfizer. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest Antonina Giammanco declares no competing interests. Rossella Spina declares no competing interests. Angelo Baldassare Cefalù has received personal fees for consultancy or grant support from Amryt, Sanofi, and Sobi. Maurizio Averna has received research grant support from Sanofi and Amryt and has served as consultant for Sanofi, Amgen, Amryt, Akcea, Ionis, Alfasigma, and Pfizer."
"Funding Open access funding provided by Università degli Studi di Palermo within the CRUI-CARE Agreement."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025